Adult obesity facts. May 14, 2024
It is to those practical clinical considerations that we turn next
With these advances, it is possible to envision a not-so-distant future wherein individual-level profiling using multiomics (e.g., genomic, transcriptomics, proteomic, epigenetic, metabolomic), biomarkers, exposomes, digital health technology, and clinical data guides precision prevention and treatment approaches to optimize brain health over the life course (Hampel et al., 2022)
1 To better understand the potential relationship between GLP-1 medications and mental health diagnoses after starting the medications, we studied 3,081,254 diabetic patients and 929,174 non-diabetic patients
It requires the use of special, often modified substances to overcome this barrier